Menek Burak, Dansuk Emre, Gorguluer Sema
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul Medipol University, Istanbul, Turkey.
Institute of Health Sciences, Department of Physiotherapy and Rehabilitation, Istanbul Medipol University, Istanbul, Turkey.
J Orthop Surg Res. 2025 Aug 30;20(1):801. doi: 10.1186/s13018-025-06238-5.
BACKGROUND: Cervical disc herniation (CDH) is a common musculoskeletal disorder characterized by chronic neck pain, impaired proprioception, kinesiophobia, and functional limitations, often requiring multimodal conservative care. Myofascial techniques, including Instrument-Assisted Soft Tissue Mobilization (IASTM) and percussion massage therapy (PMT), have emerged as supportive physiotherapy interventions. This randomized controlled trial compared the effects of IASTM and PMT on pain, disability, kinesiophobia, and proprioceptive function in individuals with CDH. METHODS: In this double-blinded RCT, 57 participants with CDH were randomly allocated to Conventional Therapy (CT), CT + PMT, or CT + IASTM (n = 19 each). Interventions were delivered three times per week for 3 weeks. PMT was applied with a percussion massage device (33-40 Hz) for 3 min to each target muscle group (trapezius, levator scapulae, cervical paravertebral) using longitudinal strokes. IASTM used stainless-steel tools on trapezius, splenius, and suboccipital muscles, with sweep and fan techniques at 30°-60°, for 9 min per session. Primary outcomes were pain (VAS) and disability (NDI); secondary outcomes included kinesiophobia (TSK) and joint position sense (JPS). Between-group differences were analyzed using ANCOVA with baseline values as covariates. RESULTS: All groups showed significant within-group improvements across all outcomes (p < 0.001). Compared to CT, both PMT and IASTM produced greater improvements in pain, kinesiophobia, and JPS (p < 0.001). VAS-rest reductions were - 4.00 ± 0.89 (d = 4.49) for IASTM, - 3.38 ± 1.95 (d = 1.74) for PMT, and - 2.13 ± 1.49 (d = 1.43) for CT. VAS-activity decreased by - 4.89 ± 1.44 (d = 3.41) for IASTM and - 3.89 ± 1.84 (d = 2.11) for PMT. NDI improved by - 11.47 ± 4.23 (d = 2.71) in IASTM, - 12.11 ± 6.86 (d = 1.76) in PMT, and - 6.63 ± 5.47 (d = 1.21) in CT, all exceeding the MCID threshold of 7.5 points. JPS-flexion improved by - 3.80 ± 1.61 (d = 2.36) in IASTM, - 3.67 ± 1.34 (d = 2.73) in PMT, and - 1.09 ± 0.84 (d = 1.29) in CT. Similar patterns occurred for extension, right rotation, and left rotation. Overall, IASTM and PMT yielded comparable improvements, suggesting similar clinical efficacy. CONCLUSIONS: IASTM and PMT provide added benefits over conventional therapy alone in managing CDH, especially in reducing pain and kinesiophobia and enhancing proprioception. Both can be effectively integrated into conservative rehabilitation programs targeting sensorimotor deficits in CDH. TRIAL REGISTRATION: Prospectively registered in the ClinicalTrials.gov registry (NCT06903000) on 24/03/2025.
背景:颈椎间盘突出症(CDH)是一种常见的肌肉骨骼疾病,其特征为慢性颈部疼痛、本体感觉受损、运动恐惧和功能受限,通常需要多模式保守治疗。肌筋膜技术,包括器械辅助软组织松动术(IASTM)和叩击按摩疗法(PMT),已成为支持性物理治疗干预措施。这项随机对照试验比较了IASTM和PMT对CDH患者疼痛、残疾、运动恐惧和本体感觉功能的影响。 方法:在这项双盲随机对照试验中,57名CDH患者被随机分配到常规治疗组(CT)、CT + PMT组或CT + IASTM组(每组n = 19)。干预措施每周进行3次,共3周。使用叩击按摩设备(33 - 40Hz)对每个目标肌肉群(斜方肌、肩胛提肌、颈椎旁肌)进行纵向叩击按摩3分钟,实施PMT。IASTM使用不锈钢工具对斜方肌、夹肌和枕下肌进行操作,采用30° - 60°的扫动和扇形技术,每次治疗9分钟。主要结局指标为疼痛(视觉模拟评分法,VAS)和残疾(颈部残疾指数,NDI);次要结局指标包括运动恐惧(运动恐惧量表,TSK)和关节位置觉(JPS)。使用协方差分析(ANCOVA)并以基线值作为协变量分析组间差异。 结果:所有组在所有结局指标上均显示出显著的组内改善(p < 0.001)。与CT组相比,PMT组和IASTM组在疼痛、运动恐惧和JPS方面均有更大改善(p < 0.001)。IASTM组VAS静息时疼痛减轻 - 4.00 ± 0.89(d = 4.49),PMT组为 - 3.38 ± 1.95(d = 1.74),CT组为 - 2.13 ± 1.49(d = 1.43)。IASTM组VAS活动时疼痛降低 - 4.89 ± 1.44(d = 3.41),PMT组为 - 3.89 ± 1.84(d = 2.11)。IASTM组NDI改善 - 11.47 ± 4.23(d = 2.71),PMT组为 - 12.11 ± 6.86(d = 1.76),CT组为 - 6.63 ± 5.47(d = 1.21),均超过最小临床重要差异阈值7.5分。IASTM组JPS屈曲改善 - 3.80 ± 1.61(d = 2.36),PMT组为 - 3.67 ± 1.34(d = 2.73),CT组为 - 1.09 ± 0.84(d = 1.29)。伸展、右旋和左旋时也出现类似模式。总体而言,IASTM和PMT产生了相当的改善,表明临床疗效相似。 结论:IASTM和PMT在管理CDH方面比单独的常规治疗具有额外益处,特别是在减轻疼痛和运动恐惧以及增强本体感觉方面。两者都可以有效地纳入针对CDH感觉运动缺陷的保守康复计划中。 试验注册:于2025年3月24日在ClinicalTrials.gov注册中心进行前瞻性注册(NCT06903000)。
Cochrane Database Syst Rev. 2015-5-21
Musculoskelet Sci Pract. 2024-11
J Back Musculoskelet Rehabil. 2024